Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM‐HF

AIMS: Elevated serum uric acid concentration (SUA) has been associated with an increased risk of cardiovascular disease, but this may be due to unmeasured confounders. We examined the association between SUA and outcomes as well as the effect of sacubitril/valsartan on SUA in patients with heart fai...

Descripción completa

Detalles Bibliográficos
Autores principales: Mogensen, Ulrik M., Køber, Lars, Jhund, Pardeep S., Desai, Akshay S., Senni, Michele, Kristensen, Søren L., Dukát, Andrej, Chen, Chen‐Huan, Ramires, Felix, Lefkowitz, Martin P., Prescott, Margaret F., Shi, Victor C., Rouleau, Jean L., Solomon, Scott D., Swedberg, Karl, Packer, Milton, McMurray, John J.V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2017
Materias:
Focus on Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607477/
https://www.ncbi.nlm.nih.gov/pubmed/29193563
http://dx.doi.org/10.1002/ejhf.1056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607477/
https://www.ncbi.nlm.nih.gov/pubmed/29193563
http://dx.doi.org/10.1002/ejhf.1056

Ejemplares similares